» Articles » PMID: 15094270

Difference in Prevalence of Congenital Cryptorchidism in Infants Between Two Nordic Countries

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2004 Apr 20
PMID 15094270
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several investigators have shown striking differences in semen quality and testicular cancer rate between Denmark and Finland. Since maldescent of the testis is a shared risk factor for these conditions we undertook a joint prospective study for the prevalence of congenital cryptorchidism.

Methods: 1068 Danish (1997-2001) and 1494 Finnish boys (1997-99) were consecutively recruited prenatally. We also established prevalence data for all newborns at Turku University Central Hospital, Finland (1997-99, n=5798). Testicular position was assessed by a standardised technique. All subtypes of congenital cryptorchidism were included, but retractile testes were considered normal.

Findings: Prevalence of cryptorchidism at birth was 9.0% (95% CI 7.3-10.8) in Denmark and 2.4% (1.7-3.3) in Finland. At 3 months of age, prevalence rates were 1.9% (1.2-3.0) and 1.0% (0.5-1.7), respectively. Significant geographic differences were still present after adjustment for confounding factors (birthweight, gestational age, being small for gestational age, maternal age, parity, mode of delivery); odds ratio (Denmark vs Finland) was 4.4 (2.9-6.7, p<0.0001) at birth and 2.2 (1.0-4.5, p=0.039) at three months. The rate in Denmark was significantly higher than that reported 40 years ago.

Interpretation: Our findings of increasing and much higher prevalence of congenital cryptorchidism in Denmark than in Finland contribute evidence to the pattern of high frequency of reproductive problems such as testicular cancer and impaired semen quality in Danish men. Although genetic factors could account for the geographic difference, the increase in reproductive health problems in Denmark is more likely explained by environmental factors, including endocrine disrupters and lifestyle.

Citing Articles

A 10-Year Retrospective Study: Is Maternal Diabetes a Risk Factor for Associated Anomalies in Males With Cryptorchidism?.

Abdullah M, Al-Taher R, Alhalasa F, Jbareen F, Nehme E, Kordi A Cureus. 2024; 16(9):e69892.

PMID: 39439600 PMC: 11494265. DOI: 10.7759/cureus.69892.


The Association between Maternal Endocrine-Disrupting Chemical Exposure during Pregnancy and the Incidence of Male Urogenital Defects: A Systematic Review and Meta-Analysis.

Albadawi E, Alzaman N, Elhassan Y, Eltahir H, Abouzied M, Albadrani M Metabolites. 2024; 14(9).

PMID: 39330484 PMC: 11434617. DOI: 10.3390/metabo14090477.


Prevalence of congenital cryptorchidism in China: A nationwide population-based surveillance study, 2007-2021.

Li W, Chen Z, Xu W, Gao Y, Liu Z, Li Q Andrology. 2024; 13(3):577-586.

PMID: 38958226 PMC: 11867920. DOI: 10.1111/andr.13686.


The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals.

Holmboe S, Beck A, Andersson A, Main K, Jorgensen N, Skakkebaek N Front Endocrinol (Lausanne). 2024; 15:1343887.

PMID: 38633762 PMC: 11021654. DOI: 10.3389/fendo.2024.1343887.


Cryptorchidism and puberty.

Rodprasert W, Virtanen H, Toppari J Front Endocrinol (Lausanne). 2024; 15:1347435.

PMID: 38532895 PMC: 10963523. DOI: 10.3389/fendo.2024.1347435.